Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients

Abstract Migraine headache is a pain condition characterized by severe and recurrent unilateral head pain. Among other mechanisms, central pain sensitization processes seem to be involved in the disorder. An experimental protocol based on slowly repeated evoked pain (SREP) has been shown to indicate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pablo de la Coba, Stephen Bruehl, Gustavo A. Reyes del Paso
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/da6469ee1bd443af83f683c2c998777d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:da6469ee1bd443af83f683c2c998777d
record_format dspace
spelling oai:doaj.org-article:da6469ee1bd443af83f683c2c998777d2021-12-02T13:30:52ZSlowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients10.1038/s41598-021-84157-12045-2322https://doaj.org/article/da6469ee1bd443af83f683c2c998777d2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84157-1https://doaj.org/toc/2045-2322Abstract Migraine headache is a pain condition characterized by severe and recurrent unilateral head pain. Among other mechanisms, central pain sensitization processes seem to be involved in the disorder. An experimental protocol based on slowly repeated evoked pain (SREP) has been shown to indicate pain sensitization in fibromyalgia patients and differentiate these patients from healthy individuals and rheumatoid arthritis patients. This study examined SREP sensitization in migraine patients and explored its potential usefulness as a central sensitization marker. The SREP protocol was administered to 40 episodic migraine (EM) patients not currently experiencing a headache and 40 healthy controls. SREP consisted of a series of 9 suprathreshold painful pressure stimuli of 5 s duration and a 30 s interstimulus interval. SREP sensitization was indexed by the increase in pain ratings across the stimuli. Pain threshold, pain tolerance and temporal summation of pain were also assessed. SREP sensitization was observed in EM, but not in healthy individuals (p < .001). SREP differentiated between EM and healthy individuals with up to 75% diagnostic accuracy. Pain threshold, pain tolerance and temporal summation of pain did not show significant discriminative ability. An SREP index value of 0.5 was the most sensitive cut-off for detecting central pain sensitization when prioritizing diagnostic sensitivity (0.88). Results provide evidence for SREP as a possible central sensitization marker with potential clinical utility in migraine patients. Inclusion of SREP in Quantitative Sensory Testing protocols may enhance the assessment of altered pain modulation in different pain conditions.Pablo de la CobaStephen BruehlGustavo A. Reyes del PasoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Pablo de la Coba
Stephen Bruehl
Gustavo A. Reyes del Paso
Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients
description Abstract Migraine headache is a pain condition characterized by severe and recurrent unilateral head pain. Among other mechanisms, central pain sensitization processes seem to be involved in the disorder. An experimental protocol based on slowly repeated evoked pain (SREP) has been shown to indicate pain sensitization in fibromyalgia patients and differentiate these patients from healthy individuals and rheumatoid arthritis patients. This study examined SREP sensitization in migraine patients and explored its potential usefulness as a central sensitization marker. The SREP protocol was administered to 40 episodic migraine (EM) patients not currently experiencing a headache and 40 healthy controls. SREP consisted of a series of 9 suprathreshold painful pressure stimuli of 5 s duration and a 30 s interstimulus interval. SREP sensitization was indexed by the increase in pain ratings across the stimuli. Pain threshold, pain tolerance and temporal summation of pain were also assessed. SREP sensitization was observed in EM, but not in healthy individuals (p < .001). SREP differentiated between EM and healthy individuals with up to 75% diagnostic accuracy. Pain threshold, pain tolerance and temporal summation of pain did not show significant discriminative ability. An SREP index value of 0.5 was the most sensitive cut-off for detecting central pain sensitization when prioritizing diagnostic sensitivity (0.88). Results provide evidence for SREP as a possible central sensitization marker with potential clinical utility in migraine patients. Inclusion of SREP in Quantitative Sensory Testing protocols may enhance the assessment of altered pain modulation in different pain conditions.
format article
author Pablo de la Coba
Stephen Bruehl
Gustavo A. Reyes del Paso
author_facet Pablo de la Coba
Stephen Bruehl
Gustavo A. Reyes del Paso
author_sort Pablo de la Coba
title Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients
title_short Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients
title_full Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients
title_fullStr Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients
title_full_unstemmed Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients
title_sort slowly repeated evoked pain (srep) as a central sensitization marker in episodic migraine patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/da6469ee1bd443af83f683c2c998777d
work_keys_str_mv AT pablodelacoba slowlyrepeatedevokedpainsrepasacentralsensitizationmarkerinepisodicmigrainepatients
AT stephenbruehl slowlyrepeatedevokedpainsrepasacentralsensitizationmarkerinepisodicmigrainepatients
AT gustavoareyesdelpaso slowlyrepeatedevokedpainsrepasacentralsensitizationmarkerinepisodicmigrainepatients
_version_ 1718392944383229952